Stage IV Adult Lymphoblastic Lymphoma Completed Phase 1 Trials for AR-42 (DB12707)

IndicationStatusPhase
DBCOND0028716 (Stage IV Adult Lymphoblastic Lymphoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01129193AR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or LymphomaTreatment